ESHB 2196: Expanding access to PANDA PANS treatment.
Did not pass. The 2025-26 session has ended.
- Sponsor
- Simmons
- Introduced
- January 12, 2026
- Status
- H Rules 3C
- Last action
- By resolution, returned to House Rules Committee for third reading. (March 12, 2026)
- As of
- October 16, 2026, 5:15 AM Pacific, from the Legislature’s records
What this bill does
Requires private fully insured health plans to provide coverage of three monthly immunomodulatory courses of intravenous immunoglobulin therapy for the treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS) if certain conditions are met.
From the Washington State Legislature's nonpartisan staff bill analysis. Read the full analysis ↗
Floor votes
- House: 3rd Reading & Final Passage · February 16, 202683 yea · 13 nay · 2 not voting
Track ESHB 2196 on OlympiaTrack
A free account adds the full hearing and amendment record, who testified, roll calls by member, and a list to track it on. Paid plans add a plain-English AI summary and an alert if its subject comes back next session.
Create a free accountOther bills sponsored by Simmons
- HB 1196: Revoking a person's voting rights only when convicted of a state crime punishable by death.
- HB 1234: Concerning the mental health counselors, marriage and family therapists, and social workers advisory committee.
- E2SHB 1432: Improving access to appropriate mental health and substance use disorder services.
- SHB 1706: Aligning the implementation of application programming interfaces for prior authorization with federal guidelines.
- SHB 2339: Concerning the regulation of nursing. (CORRECTED COPY)
All 2025-26 Washington State bills →
Source: the Washington State Legislature. OlympiaTrack is an independent bill-tracking service and is not affiliated with the Legislature. View on leg.wa.gov ↗